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The recent advantage obtained by next generation sequencing allows a depth investigation of a new “old” kind of noncoding
transcript, the circular RNAs. Circular RNAs are nontranslated RNAs, typically nonpolyadenylated, with a resistance to
exonucleases that gives them the ability to bemore stable than the common linear RNA isoforms.We used a bioinformatic detection
tool (CIRCexplorer) to research predictive circRNAs from the next generation sequenced data of five samples of ductal in situ
carcinoma (DCIS) and matched adjacent invasive ductal carcinoma (IDC). Furthermore, we also investigated the circular RNAs
expressed in MCF7, an invasive breast ductal carcinoma cell line. We described the genomic context of the predicted circular
RNAs and we address the hypothetical possible functional roles. This study showed a perspective of a panel of predictive circRNAs
identified and the function that circRNAs could exert.
1. Introduction
Annually more than a million new diagnoses worldwide for
breast cancer (BC) emerge, becoming the most common
female malignancy [1]. The term “breast cancer” refers to a
complex disease, displaying distinctive histologic and genetic
features. Dramatic changes occur in gene expression during
the transformation of normal breast tissues into ductal in
situ carcinoma (DCIS), much less important, and somewhat
surprisingly, in the transition from DCIS to invasive ductal
carcinoma (IDC). In fact, those from the same histological
subtype share very similar genetic, epigenetic alterations
and gene expression patterns. DCIS and matched adjacent
IDC (synchronous DCIS and IDC) have remarkably similar
genetic and copy number profile [2, 3].Therefore, none of the
current biomarkers, or genomic classifications, can predict if,
and when, DCIS will progress to IDC. In principle, a better
understanding of DCIS progression could highlight ways to
arrest invasion at the preinvasive stage [4]. From coding
to noncoding, high-throughput next generation sequencing
(NGS) has been analyzing in depth the entire genome at
base-pair resolution. The noncoding panorama is a real
opportunity to reveal new biomarkers or potential targets:
in this landscape long noncoding RNAs (lncRNAs) are an
emerging class of key regulatory RNAs that do not code
for protein and are not translated [5]. lncRNAs are crucial
players in various key biological processes that include dosage
compensation, genomic imprinting, chromatin organization,
gene regulation, and alternative splicing [6]. lncRNA mech-
anism of action need still to be widely revealed [7]. More
recently, the research interest is focused on circular RNAs
(circRNAs), a large class of long noncoding RNAs circular-
ized and discovered from a handful of transcribed genesmore
than twenty years ago [8]. Nowadays, there are different types
of circRNAs [9] and are known to be abundant, conserved,
and stable in cytoplasm and even in blood. At the time of the
discovery these RNA molecules had generally been consid-
ered to be of low abundance and likely representing errors in
splicing. CircRNAs are nontranslated RNAs, typically non-
polyadenylated, with a resistance to exonucleases that gives
them the ability to be more stable than the common linear
RNA isoforms, also increasing proper folding by imposing
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structural constraints on the RNA [10].Their formation is due
to a non-random back-splice event that involves in a covalent
junction between the 3󸀠 and 5󸀠 ends, providing covalently
closed continuous loops configuration, in opposition to the
theory that for decades considering the circRNAs as the result
of gene rearrangements or splicing artifacts producing rare
isoforms [10, 11]. Several studies revealed that circRNAs are
usually composed of 1 to 5 exons, where each exon can be
up to three times longer than the average expressed exon.
This perhaps suggests that the probability to circularizing for
an exon is directly proportional to the length of that exon
[12]. Although the formation mechanism and the cellular
function have been completely understood, the function
and the expressions are not clear. The majority of circRNAs
often exhibit tissue/developmental-stage-specific expression,
described recently for the brain [13]. CircRNAs are also
deregulated in cancer cell lines [11], but not many studies
have been performed yet on cancer patients. Recently, some
studies have been providing evidences about the interaction
between circRNA and miRNA, supporting a “sponge effect”
of the circRNAs as posttranscriptional regulators of other
ncRNAs, such as miRNAs [10, 14]. Based on these findings,
we will define the panel of expressed circRNAs, in DCIS
and IDC samples. We predicted strong circRNAs candidates,
enforcing their existence with an independent false discovery
polyadenylated subtraction, and then we studied the possible
roles of selected circRNAs.
2. Material and Methods
2.1. Data. Publicly available RNA-seq data of total RNA
from ten tandem DCIS/IDC samples from five patients
afflicted with DCIS that are synchronous with IDC within
the same breast (GSE66301, downloaded from the Sequence
Read Archive (SRA)) (Illumina GAII, paired-end sequencing
(2 × 75 nt length)). GSE66301 series reports data from 6
pairs of DCIS-IDC samples, we excluded one pair that has
one sample that not respected the high media level (>88%)
of the mapping quality reads percentage, showing the 49%.
Reference genome human hg19 (February 2009, GRCh37),
was downloaded from the UCSC genome browser (http://
genome.ucsc.edu/). For CIRCexplorer we used STAR as
aligner software [15]. We also used the fastq.gz samples of
the MCF7 cell line. These are public and available at the
ENCODE repository site (http://hgdownload.cse.ucsc.edu/
goldenpath/hg19/encodeDCC/): poly(A) and nonpoly(A)
selected RNA-seq data, generated with paired-end sequenc-
ing (2× 75 nt length), after the trimming quality control steps.
2.2. Data Quantification and Statistical Analysis. For circR-
NAs, each junction required supported from at least two
independent reads within the sample. The number of reads
for each circRNAs identified was used as measure of expres-
sion. The raw read counts were normalized to sequencing
depth by dividing the raw number with the number of total
reads mapped to and multiply for 109 (SRPBM: reads per
billion mapped reads). RPM (reads per million) was used
for the mRNAs. The circBase track on genome browser was
consulted to verify the annotation and if the circRNAs was
showed by other previous experiments [16]. For the enrich-
ment analysis of the potential disease involved with expres-
sion of circRNAswe used theCirc2Trait tool [17].miRTarbase
(http://miRTarBase.mbc.nctu.edu.tw/) was used to find the
genes involved in EMT and targeted by the human miR-
200b, miR-200c, and miR.429. Custom pipelines to identify:
different and common circRNAs, and to create graphics, were
performed using R software (http://www.R-project.org/).
2.3. Bioinformatic Pipeline. The raw total RNA sequencing
data, after quality control procedures (trimming), was used
for running the bioinformatic detection pipeline: CIRC-
explorer. We used this algorithm because it was one of the
mostly used and cited in many sounded scientific research;
and in comparison to other four pipelines, it has shown high
accuracy and a good sensitivity [18]. Briefly, CIRCexplorer
was focused on the identification of junction reads from
back-spliced exons and intron lariats (the terminal parts
of all unmapped reads that are aligned independently to
the genome) [19]. In parallel, we analyzed circular RNAs
expression of the total RNA-seq of MCF7, an invasive
breast ductal carcinoma cell line. This analysis revealed us
the candidates circular RNAs expressed in polyadenylated
(polyA+) and not polyA+ selected samples. Previous studies
have reported that circRNAs were nonpolyadenylated [11] or
RNase R-resistant [12], then we expected that the circRNAs
discovered using poly(A)+ selection could be the results
of miscellaneous amplification products, misalignment on
references genomes or false positives, probably not well
filtered by the quality control software. All the circRNAs,
predicted in the polyA+ samples, were considered false
positive and then used as criteria of exclusion. Basically,
we applied a false discovery polyadenylated subtraction
from the output lists of all the circRNAs candidates of
each samples. Moreover, the circRNAs were included by
at least two supporting reads. Following these selection
criteria this procedure would gave us a list of high-
confidence circRNAs. Here we listed an example of the
command parameters used for “CIRCexplorer pipeline”:
//Alignment STAR --genomeDir “hg19 index” --readFilesIn
“fastq1” “fastq2” --readFilesCommand zcat --runThreadN
8 --chimSegmentMin 20 --chimJunctionOverhangMin
20 --outFileNamePrefix $STARout dir 1≫“log file”
2≫“err file” //convert chimeric to file.txt./star parse.py
Chimeric.out.junction fusion junction.txt //search
circRNAs./CIRCexplorer.py -j fusion junction.txt -g
“GENOME.fa” -r “ANNOTATION.txt”.
3. Results and Discussion
3.1. The Genomic Context of the Predicted Circular RNAs in
Breast Cancer Samples. DCIS invasive progression has been
characterized by investigating the circRNAs expression in
tandemDCIS/IDCmodel using five samples patients afflicted
with DCIS that were synchronous with IDC within the same
breast (GSE66301) [20]. We obtained for each sample the list
of circRNAs candidates from algorithms’ output and refined









































































Figure 1: The histograms showed the presence of predicted circRNAs (𝑦-axis) related to their length (𝑥-axis) in the totality of DCIS (a) and
IDC (b) samples. The pie chart was divided into slices to illustrate numerical proportion of circRNAs predicted for each chromosome in the
totality of DCIS (c) and IDC (d) samples.
by the false positive subtraction (see Section 2 for details). As
expected, there were differences in terms of the total amount
of circRNAs identified in each sample: the CIRCexplorer
found 1938 raw circRNAs with one read. The total candidate
distinct circular RNAs that passed our criteria were 756 in
the total of the breast cancer: 552 expressed in DCIS and 208
in IDC (Supplementary Table 1 in Supplementary Material
available online at http://dx.doi.org/10.1155/2016/4503840).
Characterizing the genomic context of the predicted cir-
cRNAs, we firstly described the genomic localization of
this class of noncoding RNAs. In DCIS the 80% (443/552)
of circular RNAs belonged to the “exonic circRNAs” class
derived from back-spliced and the 20% belonged to ciRNAs
(circular intronic RNA). ciRNAs were a form of intron lariats
that have been circularized at the branchpoint 2󸀠–5󸀠 linkage;
normally degraded from the 3󸀠 end up to the branchpoint,
ciRNAs were stabilized in some way not yet clearly described.
IDC showed a different profile: 55% (112/204) were ciRNAs,
the remaining were “exonic circRNAs”. The majority of
the circular RNAs identified had a length under the 12500
nucleotides in both the classes studied (Figures 1(a) and 1(b)
and Supplementary Figure 1). The circRNAs production can
involvemore than one exon, we found up to 16 exons involved
both in DCIS and IDC. As expected, there was a significant
positive Spearman’s rank correlation between the length
and the number of exons involved in the circularization
in DCIS (rho = 0.844, 1 tail 𝑝 value < 2.2e − 16) and
IDC too (rho = 0.630, 1 tail 𝑝 value < 2.2e − 16). The
chromosomes (chr) most represented in terms of circRNAs
were showed in Figures 1(c) and 1(d): chr1, chr2, and chr3
in DCIS, while in IDC there were chr2, chr3, chr10, and
chr19.
3.2. Common and Different circRNAs Were Expressed in Syn-
chronous DCIS and IDC Samples. Two circular RNAs,
belonging to two different genes, FBXW4 and PSMA7, were
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Table 1: The 18 circRNAs expressed in at least one DCIS and IDC sample were listed. The genomic information and the chromosomal










001797 87 − 1 87 NCL ENST00000322723.4
chr2: 99976698–
99988193 NA 11495 + 8
126, 85, 673, 218, 151, 99, 90,
75 EIF5B ENST00000289371.6
chr3: 169694733–




001803 11414 + 5 106, 205, 93, 61, 120 SEC62 ENST00000337002.4
chr5: 179146668–
179146782 0075303 114 + 1 114 CANX ENST00000504734.1
chr5: 81572220–
81572269 NA 49 − 1 49 RPS23 ENST00000510019.1
chr6: 128718710–
128718833 0077818 123 − 1 123 PTPRK ENST00000368226.4
chr7: 11021998–
11030474 0133015 8476 + 2 788, 145 PHF14 ENST00000403050.3
chr9: 5968018–




NA 108 + 1 108 SMC3 ENST00000361804.4
chr11: 64888971–
64889011 NA 40 − 1 40 FAU ENST00000525297.1
chr11: 70266505–




NA 106 + 1 106 RP11-982M15.2 ENST00000557223.1
chr15: 42807434–
42807552 NA 118 + 1 118 SNAP23 ENST00000249647.3
chr17: 48271709–
48271808 NA 99 − 1 99 COL1A1 ENST00000225964.5
chr19: 50358226–
50361371 0051970 3145 + 5 108, 156, 90, 74, 58 PTOV1 ENST00000600603.1
chr19: 9938619–
9938687 NA 68 + 1 68 UBL5 ENST00000590068.1
chr20: 25252018–
25252122 NA 104 + 1 104 PYGB ENST00000216962.4
NA = not available.
found in common between the IDC samples and MCF7
cell line. These data did not reflect the gene expression
profiled studies and theymay suggest that these discrepancies
could be due to the different technology used, or that
circRNAs would be mostly related to the environment where
the cancer cells were growing. A panel of 18 circRNAs
were both expressed in at least one DCIS and IDC sample
(Table 1 and Supplementary Figure 2). Only one coding gene,
SEC62 (also named TLOC1), showed two circular RNAs
that differed in terms of number of the exons involved.
These two circRNAs were located in the chromosome region
3q26.2, that it is interestingly frequent amplified in several
cancers [21]. The longest in terms of nucleotides (11414 nts)
was the hsa-circ-0001358 (alias hsa-circ-001803), while the
second was hsa-circ-0122662, 8920 nts long. There were no
significant differences in terms of expression between these
two circRNAs comparing the levels of expression ofDCIS and
IDC classes (Wilcoxon-Mann-Whitney, 𝑝 value = 0.8). The
SEC62 mRNA was expressed more than the circular RNAs
isoforms (Figure 2(b)) and the biological trend of expression
suggested a positive correlation between the mRNA and the
two circular RNAs (Figures 2(c) and 2(d)), but this hypothesis
was not significantly confirmed by the Spearman rank test.
To figure out the possible involvements of these circRNAs
as “sponges” for the miRNAs, we investigated if there were
possible target binding sites in their sequences. Table 2 listed
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Figure 2: Schematic illustration of the two circRNAs C1 (hsa-circ-0001358) and C2 (hsa-circ-0122662) produced by the pre-mRNA of SEC62
gene. The heatmap showed the log expression values of the hsa-circ-0122662, hsa-circ-001803, and SEC62 in the two paired samples and
two unpaired (b).The scatterplot showed the correlation between SEC62 (𝑦-axes) and the two circular RNAs, respectively (𝑥-axes): hsa-circ-
0122662 and hsa-circ-0001358. Rho and 𝑝 values were obtained performing a Spearman rank test (c and d).
five possible miRNAs that can interact with the hsa-circ-
0001358, no interactions were found for the hsa-circ-0122662.
The miRNAs interacting with the circRNA were obtained
using the Starbase humanPan cancer tool [22].The alignment
scores of eachmiRNAswere showed in Supplementary Figure
3. Of note, a decreased expression of MicroRNA-200 family
(in Table 2 were listed three members: miR-200b-3p, miR-
200c-3p, and miR-429-3p) was associated to migration and
invasion of breast cancer cells in vitro in several reports
in literature [23, 24]. Therefore, we investigated the most
important genes involved in Epithelial Mesenchymal Tran-
sitions (EMT) and that were targeted by the microRNA-200
family to figure out a putative circRNA/miRNA/mRNA axis
involved in DCIS to IDC progression (Supplementary Table
2). No significant correlations were found investigating the
hsa-circ-0001358 and the ZEB1 (Zinc Finger E-Box Binding
Homeobox 1), ZEB2 (Zinc Finger E-Box Binding Home-
obox 2), and VIM (Vimentin) mRNAs levels. Intriguingly,
two targets of the miRNAs showed an opposite behavior:
BMI-1 (B lymphoma Mo-MLV insertion region 1 homolog)
positively correlated (rho = 0.886 and 𝑝 values = 0.02)
with the circ-0001358, instead FN1 (Fibronectin 1) showed a
negative correlation (rho = 0.886 and 𝑝 values = 0.02). Lastly,
using circ2traits, we searched the measure of likelihood
of the hsa-circ-0001358, to figure out possible association
with the 174 disease reported in the circ2traits database.
Breast cancer was the third on twenty-four significantly
associated disease (𝑝 value = 0.002, Supplementary Table 3).
Interestingly, we found many circRNAs expressed only in
DCIS or IDC, that could represent a difference in terms of
selected dynamic expression.This data will be in depth inves-
tigated for a better understanding of the DCIS progression to
invasive.
4. Conclusion
We have described a panel of predicted circRNAs investigat-
ing a pilot small cohort of samples having DCIS and IDC
synchronous. We have to take into account two limitations of
this study: (i) since the majority of circRNAs were expressed
at very low levels, and we analyzed total RNA sequencing
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Table 2: The table showed the five miRNAs predicted to interact with SEC62 and hsa-circ-0001358. The clip read numbers were the total
reads found in ClipSeq experiments. The bioComplex column represented the numbers of the high-throughput sequencing of RNA isolated
by crosslinking immunoprecipitation (AGO2 HITS-CLIP) of 𝑛 cell lines.
Name mirAccession TargetSites bioComplex ClipReadNum TargetLocation
hsa-miR-200c-3p MIMAT0000617 1 3 60 chr3: 169706110–169706132
hsa-miR-200b-3p MIMAT0000318 1 3 60 chr3: 169706111–169706132
hsa-miR-429 MIMAT0001536 1 3 60 chr3: 169706112–169706132
hsa-miR-376a-3p MIMAT0000729 1 8 76 chr3: 169701040–169703613
hsa-miR-376b-3p MIMAT0002172 1 8 76 chr3: 169701039–169703613
data without the use of RNase R, an enzyme that digests
linear RNAs but preserves circRNAs [25], the number of
circRNAs identified was lower respect the media of other
reports in literature. Therefore only an RNase R treatment
will permit to enrich circRNAs and then to further verify
the existence of the predicted circular RNAs. (ii) The second
weakness point was the small size of this cohort. To further
address the potential effect of the predicted circRNAs, it will
be fundamental enlarge the cohort and perform molecular
biological experiments that might permit to validate these
new findings. Altogether these data try also to shed light
on the possible involvement of a circRNA/miRNA/mRNA
axis, but these data are still preliminary and in need of a
further validation. In the next future, this class of noncoding
transcripts, still largely uncharted, will be revealed important
in biomedical studies, especially in those seeking to find
useful marker for diagnosis and prognosis and maybe to
develop new therapeutics targets.
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